Skip to main content

Animations

MJFF Publications

3661 - 3670 of 9039 Results
Title
Year
  • Year
  • 2013
  • 2018
  • 2021
  • 2013
  • 2020
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Parkinson's Disease Biomarkers: Resources for Discovery and Validation
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2013.246
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Abstracts from the 50th European Society of Human Genetics Conference: Posters
    Journal Name: European Journal of Human Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7
    Citation Count: 0
  • Dysregulated miRNAs mark Parkinson’s disease progression
    2021
    Summary Details
    RESTRICTED
    Title: Dysregulated miRNAs mark Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Money without collaboration won't bring cures
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm0213-127
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Characterization of Small-Molecule-Induced Changes in Parkinson's-Related Trafficking via the Nedd4 Ubiquitin Signaling Cascade
    Journal Name: Cell Chemical Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.chembiol.2020.10.008
    Citation Count: 22
  • Summary Details
    OPEN
    Title: The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29215
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms232314554
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells11233902
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networks
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-25454-1
    Citation Count: 10
  • Summary Details
    OPEN
    Title: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleus
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.15252/embj.2022112006
    Citation Count: 35
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.